Tag:
SEL-068
Latest Headlines
Latest Headlines
Developer looks to nanoparticles for smoking cessation vaccine
Last week, Selecta Biosciences, a 2011 Fierce 15 company , announced that it has started a Phase I trial of a synthetic nanoparticle vaccine for smoking cessation. The shot, called SEL-068, is
Selecta starts trial of synthetic nano-vaccine for smoking
Boston-based Selecta Biosciences, a 2011 Fierce 15 winner , has kicked off a Phase I trial of nicotine vaccine SEL-068 for smoking cessation and relapse prevention. The company is touting its trial as
